Will the use of anabolic androgenic steroids become a significant cardiovascular risk factor in the future?
Open Access
- 19 August 2023
- journal article
- research article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 45 (1) , 269-283
Abstract
Introduction and purpose: Cardiovascular diseases are the leading cause of mortality in many European countries. Major modifiable risk factors include dyslipidemia, hypertension, smoking and diabetes. The aim of our study is to draw attention to the possible impact of the use of anabolic androgenic steroids on increased cardiovascular risk. Brief description of the state of knowledge: Currently, an increasing proportion of the population uses anabolic-androgenic steroids (AAS). This situation applies not only to athletes, but also to amateurs. The use of AAS may be associated with numerous complications. These include an increased risk of cardiovascular disease. The literature describes the effect of AAS use on the occurrence of dyslipidemia, insulin resistance, hypertension and metabolic syndrome. All these metabolic disorders result in increased cardiovascular risk. To prevent complications, it seems best to withdraw AAS gradually under medical supervision to minimize withdrawal effects. Conclusion: The use of AAS may cause cardiovascular disease, but additional long-term studies are needed to prove this. It is necessary to sensitize patients and doctors to the problem of AAS abuse in society, because this issue can become a significant risk factor for cardiovascular diseases in near future.Keywords
This publication has 49 references indexed in Scilit:
- Left atrial myocardial dysfunction after chronic abuse of anabolic androgenic steroids: a speckle tracking echocardiography analysisThe International Journal of Cardiovascular Imaging, 2018
- Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular MechanismsCanadian Journal of Cardiology, 2018
- Vascular wall extracellular matrix proteins and vascular diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysisAnnals of Epidemiology, 2014
- Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and RhythmThe American Journal of Cardiology, 2010
- Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal womenFertility and Sterility, 2006
- Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6Diabetes Research and Clinical Practice, 2005
- Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytesJournal of Cellular Physiology, 2001
- Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aortaEuropean Journal of Pharmacology, 1994
- Contrasting effects of testosterone and stanozolol on serum lipoprotein levelsJAMA, 1989